SV2B and renal cell carcinoma: In addition, SV2B expression was substantially higher than that of SV2A and SV2C in TFE3‐RCC tissues (Figure S11D, Supporting Information), suggesting that padsevonil inhibited tumor progression in TFE3‐RCC primarily by targeting SV2B.